APO RESEARCH · REPORT
Emergency Contraceptive Pills
The prevention of pregnancy after unprotected vaginal intercourse. Emergency contraception may use drugs related to the female hormones estragon and progesterone. These "morning-after pill" are similar to birth control pills but generally contain higher hormone doses.
Product & engineering
Understand the product.
The prevention of pregnancy after unprotected vaginal intercourse. Emergency contraception may use drugs related to the female hormones estragon and progesterone. These "morning-after pill" are similar to birth control pills but generally contain higher hormone doses.
Selected research
Market Structure
Global Emergency Contraceptive Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The prevention of pregnancy after unprotected vaginal intercourse. Emergency contraception may use drugs related to the female hormones estragon and progesterone. These "morning-after pill" are similar to birth control pills but generally contain higher hormone doses.
The major players in global Emergency Contraceptive Pills market include Foundation Consumer Healthcare, Gedeon Richter, Zizhu Pharma, etc. The top 3 players occupy about 55% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 75% of the global market. Levonorgestrel is the main type, with a share over 95%. Offline is the main application, which holds a share about 90%.
This report provides an overview of the global Emergency Contraceptive Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Emergency Contraceptive Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Emergency Contraceptive Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Emergency Contraceptive Pills market size, projected growth trends, production technologies, key applications, and end-use industries.
Emergency Contraceptive Pills Segment by Company
Foundation Consumer Healthcare
Gedeon Richter
Zizhu Pharma
Zhejiang Xianju Pharma
HRA Pharma
Regenex
Mankind Pharma
Piramal
Lupin
Syzygy Healthcare
HLL Life Care
Emergency Contraceptive Pills Segment by Type
Levonorgestrel
Ulipristal Acetate
Emergency Contraceptive Pills Segment by Distribution Channel
Online
Offline
Emergency Contraceptive Pills Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Emergency Contraceptive Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Emergency Contraceptive Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Emergency Contraceptive Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Emergency Contraceptive Pills market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emergency Contraceptive Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Emergency Contraceptive Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Emergency Contraceptive Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Levonorgestrel
- Ulipristal Acetate
Applications
- Online
- Offline
Companies covered
- Foundation Consumer Healthcare
- Gedeon Richter
- Zizhu Pharma
- Zhejiang Xianju Pharma
- HRA Pharma
- Regenex
- Mankind Pharma
- Piramal
- Lupin
- Syzygy Healthcare
- HLL Life Care
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Emergency Contraceptive Pills Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Emergency Contraceptive Pills Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Emergency Contraceptive Pills Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Emergency Contraceptive Pills Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Emergency Contraceptive Pills Market Dynamics
- 2.1 Emergency Contraceptive Pills Industry Trends
- 2.2 Emergency Contraceptive Pills Industry Drivers
- 2.3 Emergency Contraceptive Pills Industry Opportunities and Challenges
- 2.4 Emergency Contraceptive Pills Industry Restraints
3 Emergency Contraceptive Pills Market by Manufacturers
- 3.1 Global Emergency Contraceptive Pills Revenue by Manufacturers (2021-2026)
- 3.2 Global Emergency Contraceptive Pills Sales by Manufacturers (2021-2026)
- 3.3 Global Emergency Contraceptive Pills Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Emergency Contraceptive Pills Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Emergency Contraceptive Pills Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Emergency Contraceptive Pills Manufacturers, Product Type & Application
- 3.7 Global Emergency Contraceptive Pills Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Emergency Contraceptive Pills Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Emergency Contraceptive Pills Players Market Share by Revenue in 2025
- 3.8.3 2025 Emergency Contraceptive Pills Tier 1, Tier 2, and Tier 3
4 Emergency Contraceptive Pills Market by Type
- 4.1 Emergency Contraceptive Pills Type Introduction
- 4.1.1 Levonorgestrel
- 4.1.2 Ulipristal Acetate
- 4.2 Global Emergency Contraceptive Pills Sales by Type
- 4.2.1 Global Emergency Contraceptive Pills Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Emergency Contraceptive Pills Sales by Type (2021-2032)
- 4.2.3 Global Emergency Contraceptive Pills Sales Market Share by Type (2021-2032)
- 4.3 Global Emergency Contraceptive Pills Revenue by Type
- 4.3.1 Global Emergency Contraceptive Pills Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Emergency Contraceptive Pills Revenue by Type (2021-2032)
- 4.3.3 Global Emergency Contraceptive Pills Revenue Market Share by Type (2021-2032)
5 Emergency Contraceptive Pills Market by Application
- 5.1 Emergency Contraceptive Pills Application Introduction
- 5.1.1 Online
- 5.1.2 Offline
- 5.2 Global Emergency Contraceptive Pills Sales by Application
- 5.2.1 Global Emergency Contraceptive Pills Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Emergency Contraceptive Pills Sales by Application (2021-2032)
- 5.2.3 Global Emergency Contraceptive Pills Sales Market Share by Application (2021-2032)
- 5.3 Global Emergency Contraceptive Pills Revenue by Application
- 5.3.1 Global Emergency Contraceptive Pills Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Emergency Contraceptive Pills Revenue by Application (2021-2032)
- 5.3.3 Global Emergency Contraceptive Pills Revenue Market Share by Application (2021-2032)
6 Global Emergency Contraceptive Pills Sales by Region
- 6.1 Global Emergency Contraceptive Pills Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Emergency Contraceptive Pills Sales by Region (2021-2032)
- 6.2.1 Global Emergency Contraceptive Pills Sales by Region (2021-2026)
- 6.2.2 Global Emergency Contraceptive Pills Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Emergency Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Emergency Contraceptive Pills Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Emergency Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Emergency Contraceptive Pills Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Emergency Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Emergency Contraceptive Pills Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Emergency Contraceptive Pills Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Emergency Contraceptive Pills Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Emergency Contraceptive Pills Revenue by Region
- 7.1 Global Emergency Contraceptive Pills Revenue by Region
- 7.1.1 Global Emergency Contraceptive Pills Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Emergency Contraceptive Pills Revenue by Region (2021-2026)
- 7.1.3 Global Emergency Contraceptive Pills Revenue by Region (2027-2032)
- 7.1.4 Global Emergency Contraceptive Pills Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Emergency Contraceptive Pills Revenue (2021-2032)
- 7.2.2 North America Emergency Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Emergency Contraceptive Pills Revenue (2021-2032)
- 7.3.2 Europe Emergency Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Emergency Contraceptive Pills Revenue (2021-2032)
- 7.4.2 Asia-Pacific Emergency Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Emergency Contraceptive Pills Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Emergency Contraceptive Pills Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Foundation Consumer Healthcare
- 8.1.1 Foundation Consumer Healthcare Company Information
- 8.1.2 Foundation Consumer Healthcare Business Overview
- 8.1.3 Foundation Consumer Healthcare Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Foundation Consumer Healthcare Emergency Contraceptive Pills Product Portfolio
- 8.1.5 Foundation Consumer Healthcare Recent Developments
- 8.2 Gedeon Richter
- 8.2.1 Gedeon Richter Company Information
- 8.2.2 Gedeon Richter Business Overview
- 8.2.3 Gedeon Richter Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Gedeon Richter Emergency Contraceptive Pills Product Portfolio
- 8.2.5 Gedeon Richter Recent Developments
- 8.3 Zizhu Pharma
- 8.3.1 Zizhu Pharma Company Information
- 8.3.2 Zizhu Pharma Business Overview
- 8.3.3 Zizhu Pharma Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Zizhu Pharma Emergency Contraceptive Pills Product Portfolio
- 8.3.5 Zizhu Pharma Recent Developments
- 8.4 Zhejiang Xianju Pharma
- 8.4.1 Zhejiang Xianju Pharma Company Information
- 8.4.2 Zhejiang Xianju Pharma Business Overview
- 8.4.3 Zhejiang Xianju Pharma Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Zhejiang Xianju Pharma Emergency Contraceptive Pills Product Portfolio
- 8.4.5 Zhejiang Xianju Pharma Recent Developments
- 8.5 HRA Pharma
- 8.5.1 HRA Pharma Company Information
- 8.5.2 HRA Pharma Business Overview
- 8.5.3 HRA Pharma Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 HRA Pharma Emergency Contraceptive Pills Product Portfolio
- 8.5.5 HRA Pharma Recent Developments
- 8.6 Regenex
- 8.6.1 Regenex Company Information
- 8.6.2 Regenex Business Overview
- 8.6.3 Regenex Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Regenex Emergency Contraceptive Pills Product Portfolio
- 8.6.5 Regenex Recent Developments
- 8.7 Mankind Pharma
- 8.7.1 Mankind Pharma Company Information
- 8.7.2 Mankind Pharma Business Overview
- 8.7.3 Mankind Pharma Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Mankind Pharma Emergency Contraceptive Pills Product Portfolio
- 8.7.5 Mankind Pharma Recent Developments
- 8.8 Piramal
- 8.8.1 Piramal Company Information
- 8.8.2 Piramal Business Overview
- 8.8.3 Piramal Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Piramal Emergency Contraceptive Pills Product Portfolio
- 8.8.5 Piramal Recent Developments
- 8.9 Lupin
- 8.9.1 Lupin Company Information
- 8.9.2 Lupin Business Overview
- 8.9.3 Lupin Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Lupin Emergency Contraceptive Pills Product Portfolio
- 8.9.5 Lupin Recent Developments
- 8.10 Syzygy Healthcare
- 8.10.1 Syzygy Healthcare Company Information
- 8.10.2 Syzygy Healthcare Business Overview
- 8.10.3 Syzygy Healthcare Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Syzygy Healthcare Emergency Contraceptive Pills Product Portfolio
- 8.10.5 Syzygy Healthcare Recent Developments
- 8.11 HLL Life Care
- 8.11.1 HLL Life Care Company Information
- 8.11.2 HLL Life Care Business Overview
- 8.11.3 HLL Life Care Emergency Contraceptive Pills Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 HLL Life Care Emergency Contraceptive Pills Product Portfolio
- 8.11.5 HLL Life Care Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Emergency Contraceptive Pills Value Chain Analysis
- 9.1.1 Emergency Contraceptive Pills Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Emergency Contraceptive Pills Production Mode & Process
- 9.2 Emergency Contraceptive Pills Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Emergency Contraceptive Pills Distributors
- 9.2.3 Emergency Contraceptive Pills Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst